| Financial Year |
March 31 2023 |
| Monetary Funds |
329,474,082.13 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
134,138,075.96 |
| Advances to Suppliers |
9,186,586.09 |
| Other Receivables |
9,417,064.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
183,317,016.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,087,090.72 |
| Total Current Assets |
679,619,915.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
58,279,000.00 |
| Fixed Assetes |
440,605,668.00 |
| Under-construction Projects |
37,963,285.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
71,689,854.56 |
| R&D expenses |
-- |
| Goodwill |
124,552,611.16 |
| Long-Term Deferred and Prepaid Expenses |
34,770,716.20 |
| Deferred Income Tax Assets |
4,067,797.53 |
| Other Non-Current Assets |
103,642,284.41 |
| Sub-Total of Non-Current Assets |
994,630,335.76 |
| Total Assets |
1,674,250,251.56 |
| Short-Term Loans |
247,442,224.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
119,487,555.17 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,897,738.20 |
| Taxes Payable |
8,369,891.45 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
107,010,967.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,672,677.28 |
| Other Current Liabilities |
27,109.22 |
| Sub-Total of Current Liabilities |
515,092,413.51 |
| Long-term Loans |
103,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
32,393,033.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
253,603,860.39 |
| Total Liabilities |
768,696,273.90 |
| Paid-In Capital(Or Share Stock) |
318,416,770.00 |
| Capital Surplus |
477,847,198.77 |
| Surplus Reserve |
54,812,358.46 |
| LESS:Treasury Stock |
63,676,816.00 |
| Undistributed Profits |
101,222,675.92 |
| Minority Stockholder's Interest |
16,613,794.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
888,940,183.27 |
| Owner's Equity（Stockholder's Equity） |
905,553,977.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,674,250,251.56 |
